Diabetes Clinical Trials in Boston

Showing 61-80 of 300 trials

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

NCT03653091

The Revita™ System is being investigated to assess the ability to improve glycemic control in conjunction with diet and exercise in patients with Type 2 diabetes who are inadequately controlled with oral anti-diabetic medications. The purpose of this study is to demonstrate the safety and effectiveness of the Fractyl DMR Procedure using the Revita™ System compared to a sham procedure. At 24 weeks, subjects randomized to the DMR procedure be continued to be followed per protocol till 48 Weeks and the Sham treatment arm will be offered to cross over to receive the DMR treatment and will be followed per protocol for 24 weeks post treatment.

Type 2 Diabetes

Fractyl Health Inc.9 participantsStarted Sep 2018

Orlando, Florida, United States • Boston, Massachusetts, United States • Lebanon, New Hampshire, United States +3 more locations

UNKNOWNNA< 1 mile

A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus

NCT05302050

Randomized, controlled, pragmatic trial with open-label extension evaluating BT-001, an investigational digital therapeutic intended to help patients with type 2 diabetes improve their glycemic control.

Diabetes Type 2

Better Therapeutics500 participantsStarted Mar 2022

Boston, Massachusetts, United States

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

VasQ External Support for Arteriovenous Fistula

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes

Look AHEAD: Action for Health in Diabetes

A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions

Replication of the TECOS Diabetes Trial in Healthcare Claims

The T1D Exchange Registry

Re-Engineered Discharge for Diabetes-Computer Adaptive Testing (REDD-CAT)

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

The International Diabetes Closed Loop (iDCL) Trial: Protocol 4

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)

The Genomic Medicine at VA Study

Mobile Health App to Reduce Diabetes in Latina Women With Prior Gestational Diabetes II

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Other Conditions in Boston